BC
LLY icon

Bridgefront Capital’s Eli Lilly LLY Stock Holding History

Bridgefront Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$560K Sell
467
-1,080
-70% -$1.1M 0.15% 232
2026
Q1 		$1.42M Buy
1,547
+886
+134% +$898K 0.35% 77
2025
Q4 		$710K Buy
+661
New +$632K 0.18% 193
2024
Q4 		– Sell
-520
Closed -$461K – 695
2024
Q3 		$461K Buy
+520
New +$468K 0.18% 197
2024
Q2 		– Sell
-282
Closed -$219K – 589
2024
Q1 		$219K Buy
+282
New +$201K 0.17% 292
2023
Q4 		– Sell
-562
Closed -$302K – 478
2023
Q3 		$302K Buy
+562
New +$290K 0.21% 198
2022
Q4 		– Sell
-621
Closed -$201K – 448
2022
Q3 		$201K Buy
+621
New +$197K 0.21% 228
2021
Q4 		– Sell
-1,103
Closed -$255K – 391
2021
Q3 		$255K Sell
1,103
-1,042
-49% -$257K 0.27% 181
2021
Q2 		$492K Sell
2,145
-186
-8% -$37.4K 0.19% 180
2021
Q1 		$435K Buy
+2,331
New +$456K 0.14% 284

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridgefront Capital's LLY Position: Q2 2026 in Review

Bridgefront Capital reduced its Eli Lilly (LLY) stake by 70% in Q2 2026, selling an estimated $1.1M and leaving 467 shares worth $560K. The position accounts for 0.15% of the portfolio, ranked #232.

Bridgefront Capital first reported a position in LLY in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.42M in Q1 2026. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bridgefront Capital held 467 shares of Eli Lilly worth $560K as of Q2 2026.
  • Bridgefront Capital sold 1,080 Eli Lilly shares in Q2 2026, an estimated $1.1M.
  • Eli Lilly made up 0.15% of Bridgefront Capital's portfolio in Q2 2026, its #232 holding.
  • Bridgefront Capital first reported a position in Eli Lilly in Q1 2021 and has held it in 10 quarters since.
  • Bridgefront Capital's Eli Lilly position peaked at $1.42M in Q1 2026.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.